InvestorsHub Logo
icon url

beachguy3363

02/28/17 7:30 AM

#24544 RE: mopar44o #24543


These guys are talking to the FDA on a constant basis and I'm assuming with the FDA now working diligently to clear up backlog by end of year they're comfortable that they will be approved. Bottom line... I think the light at the end of the tunnel is very close, meaning before end of summer we see huge upside in stock price.
icon url

Samsa

02/28/17 7:36 AM

#24545 RE: mopar44o #24543

Mopar....Thanks for that post. I must say I find that interesting. "as long as Seroquel is on the market, they dont care about the remaining ones" It is almost like they just need to manufacture 1 to generate enough cash for their research.

but why not still care about the remaining ones? that was an odd way to phrase that. This can be read a couple different ways. almost like it was never part of the plan. you throw a handful of spaghetti on the wall and hope a few stick. why not care about what the others would generate? to say it the way he did.

sorry, thats just me, always analyzing testimony. the real take away, is the hint that the dates are far enough out that they expect to get the approvals and exercise on the agreement. that there will be no impact. so that's good.
icon url

wimuskyfisherman

02/28/17 10:36 AM

#24566 RE: mopar44o #24543

Thanks Mopar for sharing!
icon url

Tekterra

02/28/17 12:57 PM

#24573 RE: mopar44o #24543

Mopar, I've been saying it, I would rather hear an approval on the other two ANDAs under MNK. Sooner rather than later. Those will improve financials for IPCI and get new valuation with the stock. Additional deals and Rexista/Podras/Regabatton deals will be turning point for this company.

But, getting the ANDA pipeline commercialized is a big deal too.